ABVC Abvc Biopharma Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ABVC

Price (delayed)

$1.8

Market cap

$46.8M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.39

Enterprise value

$49.39M

?
Relative Growth: Rel. Growth: 3
Relative Strength: Rel. Strength: 45
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 1
Highlights
ABVC's equity has soared by 99% year-on-year but it is down by 3.1% since the previous quarter
The debt has grown by 26% YoY but it has contracted by 21% from the previous quarter
ABVC's net income has dropped by 196% year-on-year and by 9% since the previous quarter
The revenue has dropped by 100% year-on-year
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of ABVC

ABVC stock price

How has the Abvc Biopharma stock price performed over time
Intraday
1.69%
1 week
24.14%
1 month
44%
1 year
-41.94%
YTD
-15.49%
QTD
13.92%

Financial performance

How have Abvc Biopharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$8.03M
Net income
-$8.63M
Gross margin
N/A
Net margin
N/A
ABVC's net income has dropped by 196% year-on-year and by 9% since the previous quarter
The revenue has dropped by 100% year-on-year
The gross profit has dropped by 100% year-on-year
ABVC's operating income is down by 12% QoQ

Price vs fundamentals

How does ABVC's price correlate with its fundamentals

Growth

What is Abvc Biopharma's growth rate over time

Valuation

What is Abvc Biopharma stock price valuation
P/E
N/A
P/B
4.25
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Abvc Biopharma's EPS has shrunk by 77% YoY
ABVC's equity has soared by 99% year-on-year but it is down by 3.1% since the previous quarter
The P/B is 18% less than the 5-year quarterly average of 5.2 and 8% less than the last 4 quarters average of 4.6
The revenue has dropped by 100% year-on-year

Efficiency

How efficient is Abvc Biopharma business performance
ABVC's ROIC has shrunk by 106% YoY
The ROA has dropped by 95% year-on-year and by 2.3% since the previous quarter
The company's return on equity has shrunk by 68% YoY but it rose by 5% QoQ

Dividends

What is ABVC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ABVC.

Financial health

How did Abvc Biopharma financials performed over time
ABVC's total assets is 186% greater than its total liabilities
The quick ratio has dropped by 80% since the previous quarter and by 65% year-on-year
ABVC's current ratio has dropped by 71% since the previous quarter and by 45% year-on-year
The debt is 75% less than the equity
ABVC's equity has soared by 99% year-on-year but it is down by 3.1% since the previous quarter
The debt to equity has declined by 38% year-on-year and by 19% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.